Machine Learning and DWI Brain Communicability Networks for Alzheimer’s Disease Detection

Signal processing and machine learning techniques are changing the clinical practice based on medical imaging from many perspectives. A major topic is related to (i) the development of computer aided diagnosis systems to provide clinicians with novel, non-invasive and low-cost support-tools, and (ii...

Full description

Bibliographic Details
Main Authors: Eufemia Lella, Angela Lombardi, Nicola Amoroso, Domenico Diacono, Tommaso Maggipinto, Alfonso Monaco, Roberto Bellotti, Sabina Tangaro
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/10/3/934
Description
Summary:Signal processing and machine learning techniques are changing the clinical practice based on medical imaging from many perspectives. A major topic is related to (i) the development of computer aided diagnosis systems to provide clinicians with novel, non-invasive and low-cost support-tools, and (ii) to the development of new methodologies for the analysis of biomedical data for finding new disease biomarkers. Advancements have been recently achieved in the context of Alzheimer&#8217;s disease (AD) diagnosis through the use of diffusion weighted imaging (DWI) data. When combined with tractography algorithms, this imaging modality enables the reconstruction of the physical connections of the brain that can be subsequently investigated through a complex network-based approach. A graph metric particularly suited to describe the disruption of the brain connectivity due to AD is <i>communicability</i>. In this work, we develop a machine learning framework for the classification and feature importance analysis of AD based on communicability at the whole brain level. We fairly compare the performance of three state-of-the-art classification models, namely support vector machines, random forests and artificial neural networks, on the connectivity networks of a balanced cohort of healthy control subjects and AD patients from the ADNI database. Moreover, we clinically validate the information content of the communicability metric by performing a feature importance analysis. Both performance comparison and feature importance analysis provide evidence of the robustness of the method. The results obtained confirm that the whole brain structural communicability alterations due to AD are a valuable <i>biomarker</i> for the characterization and investigation of pathological conditions.
ISSN:2076-3417